Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Mixed agonist–antagonist opioid with a ceiling on breathing depression. | Treats opioid addiction with a built-in safety ceiling. |
| Body system | Pain & Fever | Addiction & Recovery |
| Drug class | Opioids | Opioid substitution treatment |
| Supply | Controlled drug | Controlled drugWHO essential medicine |
| Main uses | Moderate to severe pain, Labour pain (some regions), Supplement to anaesthesia | Opioid use disorder, Pain (patches, lower doses) |
| How it works | Injectable painkiller that blocks some opioid effects. | Fills opioid receptors partially and tightly, easing cravings and blocking other opioids. |
| Starts working | 2–3 minutes (IV) | — |
| Half-life | About 5 hours | 24–42 hours |
| Typical adult dose | 10–20 mg IV, IM or SC every 3–6 hours (maximum 160 mg/day). | Started after withdrawal begins, then commonly 8–24 mg a day sublingually; injections weekly or monthly. |
| Forms | IV, IM or SC injection | Sublingual tablet, Film, Monthly/weekly injection, Patch, Combination with naloxone |
| Common side effects | Drowsiness, Sweating, Nausea, Dizziness, Headache | Constipation, Headache, Sweating, Sleep problems |
| Serious side effects | Withdrawal in opioid-dependent people, Breathing depression, Dependence (low) | Precipitated withdrawal if started too early, Breathing suppression with benzodiazepines or alcohol, Liver injury |
| Don't take if | Opioid dependence; Severe respiratory depression | — |
| Alcohol | Best avoided. Alcohol adds to sedation and breathing depression. | — |
| Pregnancy | Use with cautionMay depress newborn breathing. | Generally considered safeRecommended treatment for opioid dependence in pregnancy; newborn withdrawal is milder than with methadone. |
| Breastfeeding | Use with cautionSmall amounts in milk. | — |
| In use since | — | 1981 |
| Brand names | United States: Nubain (discontinued)United Kingdom: Nalbuphine (special import)India: Nubain, Nalbuphine (generic), Nalphin | United States: Suboxone, Sublocade, Brixadi, ButransUnited Kingdom: Subutex, Espranor, Buvidal, BuTransIndia: Addnok, Bunalone |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Not in Schedule H1 (classification unverified) | — |
| ATC code | N02AF02 | N07BC01 |
Taken together
- MajorNalbuphine + Buprenorphine: Dangerous drowsiness and slowed breathing
Opioids combined with other opioids, benzodiazepines, gabapentinoids, sleeping tablets or sedating medicines can stop breathing. Many fatal overdoses involve such combinations.
- ModerateNalbuphine + Buprenorphine: Blocked pain relief or withdrawal
Buprenorphine binds opioid receptors tightly, blocking other opioids and potentially triggering withdrawal if started too soon after them.